Journal
SEMINARS IN REPRODUCTIVE MEDICINE
Volume 24, Issue 5, Pages 340-347Publisher
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-2006-952149
Keywords
fetal tissue; fetal and cord blood; mesenchymal stem cell; hemopoietic stem cell; fetal therapy; fetomaternal microchimerism
Categories
Ask authors/readers for more resources
Fetal stem cells can be isolated not only from fetal blood and hemopoletic organs in early pregnancy, but from a variety of somatic organs as well as amniotic fluid and placenta throughout gestation. Fetal blood is a rich source of hemopoictic stem cells, which proliferate more rapidly than those in cord blood or adult bone marrow. First-trimester fetal blood, liver, and bone marrow also contain a population of mesenchymal stem cells, which appear to be more primitive with greater multipotentiality than their adult counterparts. Fetal stem cells may thus represent an intermediate cell type in the current debate focusing on dichotomized adult versus embryonic stem cells, and thus prove advantageous as a source for downstream cell therapy applications. They have also been implicated in fetomaternal trafficking in pregnancy, and in long-term microchimerism in postreproductive women.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available